Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy

Journal of Neurotrauma

Volumn 33, Issue 6, 2016, Pages 538-552

  Bramlett, Helen M ^a,b   Dietrich, W Dalton ^a   Dixon, C Edward ^c   Shear, Deborah A ^d   Schmid, Kara E ^d   Mondello, Stefania ^e   Wang, Kevin K W ^f   Hayes, Ronald L ^f   Povlishock, John T ^g   Tortella, Frank C ^d   Kochanek, Patrick M ^h  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^e UNIVERSITY OF MESSINA   (Italy)

^f UNIVERSITY OF FLORIDA HEALTH   (United States)

^g VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

biomarker; controlled cortical impact; fluid percussion; neuroprotection; penetrating ballistic like brain injury; rat; therapy

Indexed keywords

BIOLOGICAL MARKER; GLIAL FIBRILLARY ACIDIC PROTEIN; RECOMBINANT ERYTHROPOIETIN; UBIQUITIN THIOLESTERASE; UBIQUITIN THIOLESTERASE L1; UNCLASSIFIED DRUG; ERYTHROPOIETIN; NEUROPROTECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; CRANIOTOMY; DRUG SCREENING; FLUID PERCUSSION BRAIN INJURY; GUNSHOT INJURY; HEMISPHERE; HISTOPATHOLOGY; MORRIS WATER MAZE TEST; NEUROPROTECTION; NONHUMAN; OPERATION BRAIN TRAUMA THERAPY; OUTCOME ASSESSMENT; PENETRATING BALLISTIC LIKE BRAIN INJURY; PENETRATING TRAUMA; PERCUSSION; RAT; TRAUMATIC BRAIN INJURY; ANIMAL; BLOOD; CONVALESCENCE; DISEASE MODEL; DRUG EFFECTS; MALE; SPRAGUE DAWLEY RAT;

ANIMALS; BIOMARKERS; BRAIN INJURIES, TRAUMATIC; DISEASE MODELS, ANIMAL; ERYTHROPOIETIN; GLIAL FIBRILLARY ACIDIC PROTEIN; MALE; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; RECOVERY OF FUNCTION; UBIQUITIN THIOLESTERASE;

EID: 84962245540     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.2015.4116     Document Type: Article

References (48)

1. Langlois JA, Rutland-Brown,W., and Thomas, K.E. (2006). Traumatic brain injury in the United States: emergency department visits, hospitalizations, and deaths. Centers for Disease Control and Prevention, National Center for Injury Prevention and Control: Atlanta, GA. Available at: http://www.cdc.gov/ncipc/pub-res/TBI-in-US-04/TBI-ED.htm.
2. Toth, A., Kovacs, N., Perlaki, G., Orsi, G., Aradi, M., Komaromy, H., Ezer, E., Bukovics, P., Farkas, O., Janszky, J., Doczi, T., Buki, A., and Schwarcz, A. (2013). Multi-modal magnetic resonance imaging in the acute and sub-acute phase of mild traumatic brain injury: can we see the difference? J. Neurotrauma 30, 2-10.
3. Andersson, E.H., Bjorklund, R., Emanuelson, I., and Stalhammar, D. (2003). Epidemiology of traumatic brain injury: a population based study in western Sweden. Acta Neurol. Scand. 107, 256-259.
4. Thurman, D.J., Alverson, C., Dunn, K.A., Guerrero, J., and Sniezek, J.E. (1999). Traumatic brain injury in the United States: A public health perspective. J. Head Trauma Rehabil. 14, 602-615.
5. Maas, A.I., Roozenbeek, B., and Manley, G.T. (2010). Clinical trials in traumatic brain injury: past experience and current developments. Neurotherapeutics 7, 115-126.
6. Cherian, L., Goodman, J.C., and Robertson, C. (2007). Neuroprotection with erythropoietin administration following controlled cortical impact injury in rats. J. Pharmacol. Exp. Ther. 322, 789-794.
7. Lu, D., Mahmood, A., Qu, C., Goussev, A., Schallert, T., and Chopp, M. (2005). Erythropoietin enhances neurogenesis and restores spatial memory in rats after traumatic brain injury. J. Neurotrauma 22, 1011-1017.
8. Ning, R., Xiong, Y., Mahmood, A., Zhang, Y., Meng, Y., Qu, C., and Chopp, M. (2011). Erythropoietin promotes neurovascular remodeling and long-term functional recovery in rats following traumatic brain injury. Brain Res. 1384, 140-150.
9. Xiong, Y., Lu, D., Qu, C., Goussev, A., Schallert, T., Mahmood, A., and Chopp, M. (2008). Effects of erythropoietin on reducing brain damage and improving functional outcome after traumatic brain injury in mice. J. Neurosurg. 109, 510-521.
10. Xiong, Y., Mahmood, A., Lu, D., Qu, C., Kazmi, H., Goussev, A., Zhang, Z.G., Noguchi, C.T., Schallert, T., and Chopp, M. (2008). Histological and functional outcomes after traumatic brain injury in mice null for the erythropoietin receptor in the central nervous system. Brain Res. 1230, 247-257.
11. Xiong, Y., Mahmood, A., Meng, Y., Zhang, Y., Qu, C., Schallert, T., and Chopp, M. (2010). Delayed administration of erythropoietin reducing hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome following traumatic brain injury in rats: comparison of treatment with single and triple dose. J. Neurosurg. 113, 598-608.
12. Xiong, Y., Mahmood, A., Qu, C., Kazmi, H., Zhang, Z.G., Noguchi, C.T., Schallert, T., and Chopp, M. (2010). Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor. J. Neurotrauma 27, 205-215.
13. Xiong, Y., Mahmood, A., Zhang, Y., Meng, Y., Zhang, Z.G., Qu, C., Sager, T.N., and Chopp, M. (2011). Effects of posttraumatic carbamylated erythropoietin therapy on reducing lesion volume and hippocampal cell loss, enhancing angiogenesis and neurogenesis, and improving functional outcome in rats following traumatic brain injury. J. Neurosurg. 114, 549-559.
14. Xiong, Y., Zhang, Y., Mahmood, A., Meng, Y., Qu, C., and Chopp, M. (2011). Erythropoietin mediates neurobehavioral recovery and neurovascular remodeling following traumatic brain injury in rats by increasing expression of vascular endothelial growth factor. Transl. Stroke Res. 2, 619-632.
15. Yatsiv, I., Grigoriadis, N., Simeonidou, C., Stahel, P.F., Schmidt, O.I., Alexandrovitch, A.G., Tsenter, J., and Shohami, E. (2005). Erythropoietin is neuroprotective, improves functional recovery, and reduces neuronal apoptosis and inflammation in a rodent model of experimental closed head injury. FASEB J. 19, 1701-1703.
16. Robertson, C.S., Hannay, H.J., Yamal, J.M., Gopinath, S., Goodman, J.C., Tilley, B.C., and the Epo Severe TBI Trial Investigators. (2014). Effect of erythropoietin and transfusion threshold on neurological recovery after traumatic brain injury. A randomized clinical trial. JAMA 312, 36-47.
17. Lin, F.K., Suggs, S., Lin, C.H., Browne, J.K., Smalling, R., Egrie, J.C., Chen, K.K., Fox, G.M., Martin, F., Stabinsky, Z. Badrawi, S.M., Por-Hsiung, L., and Goldwasser, E. (1985). Cloning and expression of the human erythropoietin gene. Proc. Natl. Acad. Sci. U. S. A. 82, 7580-7584.
18. Marti, H.H., Wenger, R.H., Rivas, L.A., Straumann, U., Digicaylioglu, M., Henn, V., Yonekawa, Y., Bauer, C., and Gassmann, M. (1996). Erythropoietin gene expression in human, monkey and murine brain. Eur. J. Neurosci. 8, 666-676.
19. Warnecke, C., Zaborowska, Z., Kurreck, J., Erdmann, V.A., Frei, U., Wiesener, M., and Eckardt, K.U. (2004). Differentiating the functional role of hypoxia-inducible factor (HIF)-1alpha and HIF-2alpha (EPAS-1) by the use of RNA interference: erythropoietin is a HIF-2alpha target gene in Hep3B and Kelly cells. FASEB J. 18, 1462-1464.
20. Ponce, L.L., Navarro, J.C., Ahmed, O., and Robertson, C.S. (2013). Erythropoietin neuroprotection with traumatic brain injury. Pathophysiology 20, 31-38.
21. Meng, Y., Xiong, Y., Mahmood, A., Zhang, Y., Qu, C., and Chopp, M. (2011). Dose-dependent neurorestorative effects of delayed treatment of traumatic brain injury with recombinant human erythropoietin in rats. J. Neurosurg. 115, 550-560.
22. Brines, M.L., Ghezzi, P., Keenan, S., Agnello, D., de Lanerolle, N.C., Cerami, C., Itri, L.M., and Cerami, A. (2000). Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci. U. S. A. 97, 10526-10531.
23. Valable, S., Francony, G., Bouzat, P., Fevre, M.C., Mahious, N., Bouet, V., Farion, R., Barbier, E., Lahrech, H., Remy, C., Petit, E., Segebarth, C., Bernaudin, M., and Payen, J.F. (2010). The impact of erythropoietin on short-term changes in phosphorylation of brain protein kinases in a rat model of traumatic brain injury. J. Cereb. Blood Flow Metab. 30, 361-369.
24. Liao, Z.B., Jiang, G.Y., Tang, Z.H., Zhi, X.G., Sun, X.C., Tang, W.Y., and Wu, M.J. (2009). Erythropoietin can promote survival of cerebral cells by downregulating Bax gene after traumatic brain injury in rats. Neurol. India 57, 722-728.
25. Jin, W., Kong, J., Lu, T., Wang, H., Ni, H., Wu, J., Dai, Y., Jiang, J., and Liang, W. (2011). Erythropoietin prevents secondary brain injury induced by cortical lesion in mice: possible involvement of Nrf2 signaling pathway. Ann. Clin. Lab. Sci. 41, 25-32.
26. Jin, W., Wu, J., Wang, H., Kong, J., Ni, H., and Liang, W. (2011). Erythropoietin administration modulates pulmonary Nrf2 signaling pathway after traumatic brain injury in mice. J. Trauma 71, 680-686.
27. Shear, D.A., Dixon, C.E., Bramlett, H.M., Mondello, S., Dietrich, W.D., Deng-Bryant, Y., Schmid, K.E., Wang, K.K.W., Hayes, R.L., Povlishock, J.T., Kochanek, P.M., and Tortella, F.C. (2016). Nicotinamide treatment in traumatic brain injury: Operation brain trauma therapy. J. Neurotrauma 33, 523-537.
28. Atkins, C.M., Truettner, J.S., Lotocki, G., Sanchez-Molano, J., Kang, Y., Alonso, O.F., Sick, T.J., Dietrich, W.D., and Bramlett, H.M. (2010). Post-traumatic seizure susceptibility is attenuated by hypothermia therapy. Eur. J. Neurosci. 32, 1912-1920.
29. Dixon, C.E., Clifton, G.L., Lighthall, J.W., Yaghmai, A.A., and Hayes, R.L. (1991). A controlled cortical impact model of traumatic brain injury in the rat. J. Neurosci. Methods 39, 253-262.
30. Shear, D.A., Lu, X.C., Bombard, M.C., Pedersen, R., Chen, Z., Davis, A., and Tortella, F.C. (2010). Longitudinal characterization of motor and cognitive deficits in a model of penetrating ballistic-like brain injury. J. Neurotrauma 27, 1911-1923.
31. Mondello, S., Shear, D.A., Bramlett, H.M., Dixon, C.E., Schmid, K.E., Dietrich, W.D., Wang, K.K. W., Hayes, R.L., Glushakova, O., Catania, M., Richieri, S.P., Povlishock, J. T., Tortella, F.C., and Kochanek, P.M. (2016). Insight into preclinical models of traumatic brain injury using circulating brain damage biomarkers: Operation brain trauma therapy. J. Neurotrauma 33, 595-605.
32. Blaya, M.O., Bramlett, H.M., Nadoo, J., Pieper, A.A., and Dietrich, W.D., 3rd (2014). Neuroprotective efficacy of a proneurogenic compound after traumatic brain injury. J. Neurotrauma 31, 476-486.
33. Dixon, C.E., Markgraf, C.G., Angileri, F., Pike, B.R., Wolfson, B., Newcomb, J.K., Bismar, M.M., Blanco, A.J., Clifton, G.L., and Hayes, R.L. (1998). Protective effects of moderate hypothermia on behavioral deficits but not necrotic cavitation following cortical impact injury in the rat. J. Neurotrauma 15, 95-103.
34. Bederson, J.B., Pitts, L.H., Tsuji, M., Nishimura, M.C., Davis, R.L., and Bartkowski, H. (1986). Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination. Stroke 17, 472-476.
35. Kochanek, P.M., Bramlett, H.M., Dixon, C.E., Shear, D.A., Dietrich, W.D., Schmid, K.E., Mondello, S., Wang, K.K.W., Hayes, R.L., Povlishock, J.T., and Tortella, F.C. (2016). Approach to modeling, therapy evaluation, drug selection, and biomarker assessments, for a multicenter pre-clinical drug screening consortium for acute therapies in severe traumatic brain injury: Operation brain trauma therapy. J. Neurotrauma 33, 513-522.
36. Hartley, C.E., Varma, M., Fischer, J.P., Riccardi, R., Strauss, J.A., Shah, S., Zhang, S., and Yang, Z.J. (2008). Neuroprotective effects of erythropoietin on acute metabolic and pathological changes in experimentally induced neurotrauma. J. Neurosurg. 109, 708-714.
37. Ehrenreich, H., Weissenborn, K., Prange, H., Schneider, D., Weimar, C., Wartenberg, K., Schellinger, P.D., Bohn, M., Becker, H., Wegrzyn, M., Jahnig, P., Herrmann, M., Knauth, M., Bahr, M., Heide, W., Wagner, A., Schwab, S., Reichmann,.H., Schwendemann, G., Dengler, R., Kastrup, A., Bartels, C., and the EPO Stroke Trial Group. (2009). Recombinant human erythropoietin in the treatment of acute ischemic stroke. Stroke 40, e647-e656.
38. Bian, X.X., Yuan, X.S., and Qi, C.P. (2010). Effect of recombinant human erythropoietin on serum S100B protein and interleukin-6 levels after traumatic brain injury in the rat. Neurol. Med. Chir. (Tokyo) 50, 361-366.
39. Nirula, R., Diaz-Arrastia, R., Brasel, K., Weigelt, J.A., and Waxman, K. (2010). Safety and efficacy of erythropoietin in traumatic brain injury patients: a pilot randomized trial. Crit. Care Res. Pract. 2010, 2010.
40. Corwin, H.L., Gettinger, A., Fabian, T.C., May, A., Pearl, R.G., Heard, S., An, R., Bowers, P.J., Burton, P., Klausner, M.A., Corwin, M.J., and EPO Critical Care Trials Group. (2007). Efficacy and safety of epoetin alfa in critically ill patients. N. Engl. J. Med. 357, 965-976.
41. Leist, M., Ghezzi, P., Grasso, G., Bianchi, R., Villa, P., Fratelli, M., Savino, C., Bianchi, M., Nielsen, J., Gerwien, J., Kallunki, P., Larsen, A.K., Helboe, L., Christensen, S., Pedersen, L.O., Nielsen, M., Torup, L., Sager, T., Sfacteria, A., Erbayraktar, S., Erbayraktar, Z., Gokmen, N., Yilmaz, O., Cerami-Hand, C., Xie, Q.W., Coleman, T., Cerami, A., and Brines, M. (2004). Derivatives of erythropoietin that are tissue protective but not erythropoietic. Science 305, 239-242.
42. Brines, M., Patel, N.S., Villa, P., Brines, C., Mennini, T., De Paola, M., Erbayraktar, Z., Erbayraktar, S., Sepodes, B., Thiemermann, C., Ghezzi, P., Yamin, M., Hand, C.C., Xie, Q.W., Coleman, T., and Cerami, A. (2008). Nonerythropoietic, tissue-protective peptides derived from the tertiary structure of erythropoietin. Proc. Natl. Acad. Sci. U. S. A. 105, 10925-10930.
43. Robertson, C.S., Cherian, L., Shah, M., Garcia, R., Navarro, J.C., Grill, R.J., Hand, C.C., Tian, T.S., and Hannay, H.J. (2012). Neuroprotection with an erythropoietin mimetic peptide (pHBSP) in a model of mild traumatic brain injury complicated by hemorrhagic shock. J. Neurotrauma 29, 1156-1166.
44. Robertson, C.S., Garcia, R., Gaddam, S.S., Grill, R.J., Cerami Hand, C., Tian, T.S., and Hannay, H.J. (2013). Treatment of mild traumatic brain injury with an erythropoietin-mimetic peptide. J. Neurotrauma 30, 765-774.
45. Lieutaud, T., Andrews, P.J., Rhodes, J.K., and Williamson, R. (2008). Characterization of the pharmacokinetics of human recombinant erythropoietin in blood and brain when administered immediately after lateral fluid percussion brain injury and its pharmacodynamic effects on IL-1beta and MIP-2 in rats. J. Neurotrauma. 25, 1179-1185.
46. Oztürk, E., Demirbilek, S., Köroğlu, A, But, A., Begeç, Z.O., Gülec, M., Akyol, O., and Ersoy, M.O. (2008). Propofol and erythropoietin antioxidant properties in rat brain injured tissue. Prog. Neuropsychopharmacol. Biol. Psychiatry 32, 81-86.
47. Verdonck, O., Lahrech, H., Francony, G., Carle, O., Farion, R., Van de Looij, Y., Remy, C., Segebarth, C., and Payen, J.F. (2007). Erythropoietin protects from post-traumatic edema in the rat brain. J. Cereb. Blood Flow Metab. 27, 1369-1376.
48. Akdemir Ozisik, P., Oruckaptan, H., Ozdemir Geyik, P., Misirlioglu, M., Sargon, M.F., Kilinc, K., and Ozgen, T. (2007). Effect of erythropoietin on brain tissue after experimental head trauma in rats. Surg. Neurol. 68, 547-555.